Vanessa L. Ford

Array ( [id] => 7527597 [patent_doc_number] => 08044189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Bacillus anthracis protective antigen nucleic acid sequences' [patent_app_type] => utility [patent_app_number] => 12/816285 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10691 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044189.pdf [firstpage_image] =>[orig_patent_app_number] => 12816285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234934 [patent_doc_number] => 20100266638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'HEADACHE TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 12/793603 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 40820 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266638.pdf [firstpage_image] =>[orig_patent_app_number] => 12793603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582308 [patent_doc_number] => 20100291138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 12/793408 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21840 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291138.pdf [firstpage_image] =>[orig_patent_app_number] => 12793408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148792 [patent_doc_number] => 20110020387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'MALARIA VACCINE' [patent_app_type] => utility [patent_app_number] => 12/793575 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12376 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020387.pdf [firstpage_image] =>[orig_patent_app_number] => 12793575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231508 [patent_doc_number] => 20100184689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Pharmaceutical Composition Containing Botulinum Neurotoxin' [patent_app_type] => utility [patent_app_number] => 12/748733 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8035 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184689.pdf [firstpage_image] =>[orig_patent_app_number] => 12748733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6418447 [patent_doc_number] => 20100167393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN' [patent_app_type] => utility [patent_app_number] => 12/723499 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12675 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167393.pdf [firstpage_image] =>[orig_patent_app_number] => 12723499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7686074 [patent_doc_number] => 20100120067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'H. Meleagridis Assay' [patent_app_type] => utility [patent_app_number] => 12/617420 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6218 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120067.pdf [firstpage_image] =>[orig_patent_app_number] => 12617420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314537 [patent_doc_number] => 20100112005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Compositions of activated botulinum toxin type B' [patent_app_type] => utility [patent_app_number] => 12/590113 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6556 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112005.pdf [firstpage_image] =>[orig_patent_app_number] => 12590113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374602 [patent_doc_number] => 20100081156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/604138 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21815 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081156.pdf [firstpage_image] =>[orig_patent_app_number] => 12604138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374597 [patent_doc_number] => 20100081155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/604059 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21828 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081155.pdf [firstpage_image] =>[orig_patent_app_number] => 12604059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302513 [patent_doc_number] => 20100068232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Methods for treating skin lines and wrinkles and improving skin quality' [patent_app_type] => utility [patent_app_number] => 12/583944 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 9938 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068232.pdf [firstpage_image] =>[orig_patent_app_number] => 12583944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625939 [patent_doc_number] => 20100034853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Compositions of activated botulinum toxin type B' [patent_app_type] => utility [patent_app_number] => 12/462559 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6170 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20100034853.pdf [firstpage_image] =>[orig_patent_app_number] => 12462559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367189 [patent_doc_number] => 20090304748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/498293 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24743 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304748.pdf [firstpage_image] =>[orig_patent_app_number] => 12498293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551870 [patent_doc_number] => 20090285856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'HELICOBACTER SPECIES AND CULTIVATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/463300 [patent_app_country] => US [patent_app_date] => 2009-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17783 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285856.pdf [firstpage_image] =>[orig_patent_app_number] => 12463300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569384 [patent_doc_number] => 20090252762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => ' NOVEL PROTEOSOME-LIPOSACCHARIDE VACCINE ADJUVANT' [patent_app_type] => utility [patent_app_number] => 12/414497 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10341 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252762.pdf [firstpage_image] =>[orig_patent_app_number] => 12414497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13026 [patent_doc_number] => 07803389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Toxoplasma gondii mutant with enhanced homologous recombination and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/394365 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 31 [patent_no_of_words] => 31422 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803389.pdf [firstpage_image] =>[orig_patent_app_number] => 12394365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501709 [patent_doc_number] => 20090162397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'HEAT TREATED BACTERINS, AND EMULSION VACCINES PREPARED FROM SUCH HEAT TREATED BACTERINS' [patent_app_type] => utility [patent_app_number] => 12/335152 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4539 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162397.pdf [firstpage_image] =>[orig_patent_app_number] => 12335152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199324 [patent_doc_number] => 20120122802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/331816 [patent_app_country] => US [patent_app_date] => 2008-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41818 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122802.pdf [firstpage_image] =>[orig_patent_app_number] => 12331816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379403 [patent_doc_number] => 20090191242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'NOVEL HOMEOPATHIC STRAIN COMPRISING A NOSODE FROM A PROTOZOON OF THE GENUS TRYPANOSOMA' [patent_app_type] => utility [patent_app_number] => 12/330049 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3548 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191242.pdf [firstpage_image] =>[orig_patent_app_number] => 12330049 [rel_patent_id] =>[rel_patent_doc_number] =>)